Dr. Jeffrey Weitzel discusses BRCA testing and who benefits from testing at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr.Weitzel’s multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased [...]

Musa Mayer, a research advocate and founder of the website, AdvancedBC.org, talks about her journey as an advocate for metastatic breast cancer. Advocacy in Action videos at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium was made possible by support from: VIDEO TRANSCRIPT: Selma Schimmel, Founder & CEO, Vital Options International I’ve very pleased [...]

Elyse Spatz Caplan, Director of Programs and Partnerships with Living Beyond Breast Cancer, discusses the organization in depth including their mission, the launch of the new website at LBBC.org and all of the various ways in which they disseminate information to women living with and beyond breast cancer. For more information on Living Beyond Breast [...]

The 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium was a huge success! We produced more than 20 interviews on topics ranging from the BOLERO-2 and CLEOPATRA trials (Jose Baselga) to medical economics (Eric Winer), breast cancer and the environment (Robert Hiatt), the treatment of young women with breast cancer (Ann Partridge), metastatic breast cancer [...]

  Dr. C. Kent Osborne, the co-director of the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), discusses breast cancer advances and treatment highlights over the past year. He highlights three areas which he thinks will be practice changing: the overall treatment of HER2-positive breast cancer, the findings from the BOLERO-2 trial and the use of [...]

  Dr. Jose Baselga discusses the exciting data for the HER2-negative breast cancer patient — the BOLERO-2 trial released at the CTRC-AACR 34th Annual San Antonio Breast Cancer Symposium. Dr. Baselga is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard [...]

  Dr. Jose Baselga discusses the exciting data for the HER2-positive breast cancer patient — the CLEOPATRA trial released at the CTRC-AACR 34th Annual San Antonio Breast Cancer Symposium. Dr. Baselga is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard [...]

  Dr. Eric Winer presented one of the plenary sessions at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. His talk was on endocrine therapy and looking into the future. His prognosis asks the question: Why haven’t we done better? And he addresses, what he believes, are the three key issues. Dr. Winer is [...]

  Dr. Robert A. Hiatt discusses the Institute of Medicine Report on Breast Cancer and the Environment: A Life-Course Approach, presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. The report urges a life-course approach to studying breast cancer because new information suggests that women and girls might be more susceptible to some [...]

Dr. Julie R. Gralow discusses the SWOG SO226 where postmenopausal women with metastatic breast cancer given first-line treatment of fulvestrant (Faslodex) and anastrozole (Arimidix) have a better progression-free survival (PFS) than those given anastrozole alone. She also gives an update on bisphosphonates and osteonecrosis of the jaw at the 34th Annual CTRC-AACR San Antonio Breast [...]